475 related articles for article (PubMed ID: 33574756)
21. The novel zoonotic COVID-19 pandemic: An expected global health concern.
Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
[TBL] [Abstract][Full Text] [Related]
22. Outbreak of COVID-19: A Detailed Overview and Its Consequences.
Shivalkar S; Pingali MS; Verma A; Singh A; Singh V; Paital B; Das D; Varadwaj PK; Samanta SK
Adv Exp Med Biol; 2021; 1353():23-45. PubMed ID: 35137366
[TBL] [Abstract][Full Text] [Related]
23. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
[TBL] [Abstract][Full Text] [Related]
24. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
26. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
[TBL] [Abstract][Full Text] [Related]
27. Cell-Mediated Immune Responses to COVID-19 Infection.
Guihot A; Litvinova E; Autran B; Debré P; Vieillard V
Front Immunol; 2020; 11():1662. PubMed ID: 32719687
[TBL] [Abstract][Full Text] [Related]
28. A Review on Currently Available Potential Therapeutic Options for COVID-19.
Ohadian Moghadam S
Int J Gen Med; 2020; 13():443-467. PubMed ID: 32801840
[TBL] [Abstract][Full Text] [Related]
29. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
30. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
Hon KL; Leung KKY; Leung AK; Qian SY; Chan VP; Ip P; Wong IC
Drugs Context; 2020; 9():. PubMed ID: 32655654
[TBL] [Abstract][Full Text] [Related]
31. Coronavirus disease - COVID-19: new perceptives towards epidemic to pandemic.
Santhosh SB; Mohamed Sheik Tharik A; Susitra Manjari M; Balakrishnan R; Muruganandam N; Chandrasekar MJN
J Drug Target; 2020; 28(7-8):755-759. PubMed ID: 32729367
[TBL] [Abstract][Full Text] [Related]
32. Coronavirus disease 2019: reassembly attack of coronavirus.
Yang C; Qiu X; Fan H; Jiang M; Lao X; Zeng Y; Zhang Z
Int J Environ Health Res; 2022 Feb; 32(2):243-251. PubMed ID: 32316751
[TBL] [Abstract][Full Text] [Related]
33. Towards a more effective strategy for COVID-19 prevention (Review).
Szkaradkiewicz-Karpińska AK; Szkaradkiewicz A
Exp Ther Med; 2021 Jan; 21(1):33. PubMed ID: 33262819
[TBL] [Abstract][Full Text] [Related]
34. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
35. Testing the identification effectiveness of an unknown outbreak of the Infectious Diseases Seeker (IDS) using and comparing the novel coronavirus disease (COVID-19) outbreak with the past SARS and MERS epidemics.
Baldassi F; Cenciarelli O; Malizia A; Gaudio P
J Infect Public Health; 2021 Jan; 14(1):123-130. PubMed ID: 33412372
[TBL] [Abstract][Full Text] [Related]
36. COVID-19: Immunology, Immunopathogenesis and Potential Therapies.
Bhardwaj A; Sapra L; Saini C; Azam Z; Mishra PK; Verma B; Mishra GC; Srivastava RK
Int Rev Immunol; 2022; 41(2):171-206. PubMed ID: 33641587
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 infection: a global outbreak and its implication on public health.
Mohan S; Anjum MR; Kodidasu A; Prathyusha TVNS; Mrunalini NV; Kishori B
Bull Natl Res Cent; 2021; 45(1):139. PubMed ID: 34366657
[TBL] [Abstract][Full Text] [Related]
38. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
40. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
